Table 2. Relationship between the clinical features of pancreatic cancer and FAM64A expression.

Features	Variable	n	FAM64A (%)				χ2	P
			High		Low
Age	<55 years	34	18	-15.38	16	-25.81	2.224	0.136
	≥55 years	145	99	-84.62	46	-74.19
Gender	Female	80	55	-47.01	25	-40.32	0.487	0.485
	Male	99	62	-52.99	37	-59.68
Alcohol use history	No	65	43	-39.81	22	-37.29	0.024	0.878
	Yes	102	65	-60.19	37	-62.71
Anatomic location	Body of pancreas	14	9	-7.69	5	-8.06	3.288	0.349
	Head of pancreas	139	88	-75.21	51	-82.26
	Other	11	7	-5.98	4	-6.45
	Tail of pancreas	15	13	-11.11	2	-3.23
Histological type	Adenocarcinoma Other subtype	26	14	-12.07	12	-19.35	2.319	0.509
	Adenocarcinoma ductal type	147	98	-84.48	49	-79.03
	Colloid carcinoma	4	3	-2.59	1	-1.61
	Undifferentiated carcinoma	1	1	-0.86	0	0
Histologic grade	G1	31	16	-13.68	15	-24.19	4.334	0.363
	G2	96	65	-55.56	31	-50
	G3	48	33	-28.21	15	-24.19
	G4	2	1	-0.85	1	-1.61
	GX	2	2	-1.71	0	0
Stage	I	21	12	-10.34	9	-14.75	1.290	0.732
	II	147	97	-83.62	50	-81.97
	III	4	3	-2.59	1	-1.64
	IV	5	4	-3.45	1	-1.64
T classification	T1	7	4	-3.45	3	-4.84	3.799	0.434
	T2	24	13	-11.21	11	-17.74
	T3	143	97	-83.62	46	-74.19
	T4	3	2	-1.72	1	-1.61
	TX	1	0	0	1	-1.61
N classification	N0	50	38	-32.48	12	-19.67	3.507	0.173
	N1	124	77	-65.81	47	-77.05
	NX	4	2	-1.71	2	-3.28
M classification	M0	80	50	-42.74	30	-48.39	0.877	0.645
	M1	5	4	-3.42	1	-1.61
	MX	94	63	-53.85	31	-50
Residual tumor	R0	107	68	-62.39	39	-65	0.334	0.954
	R1	53	35	-32.11	18	-30
	R2	5	3	-2.75	2	-3.33
	RX	4	3	-2.75	1	-1.67
Survival status	Death	93	71	-60.68	22	-35.48	9.325	0.002
	Survival	86	46	-39.32	40	-64.52
Recurrence	No	98	55	-56.12	43	-74.14	4.321	0.038
	Yes	58	43	-43.88	15	-25.86

Bold values indicate P<0.05.